Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3412)
All Articles published online
|
Publishing Process of This Article
|
Dec 26, 2021 (publication date) through Jun 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Javed A, Ajmal M, Wolfson A. Dabigatran in cardiovascular disease management: A comprehensive review. World J Cardiol 2021; 13(12): 710-719 [PMID: 35070113 DOI: 10.4330/wjc.v13.i12.710] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v13/i12/710.htm |
| Number | Citing Articles |
| 1 |
Kong-Nan Zhao, Paul Masci, Goce Dimeski, Lambro Johnson, Michael Grant, John de Jersey, Martin Lavin. Potential Application of Recombinant Snake Prothrombin Activator Ecarin in Blood Diagnostics. Biomolecules 2022; 12(11): 1704 doi: 10.3390/biom12111704
|
| 2 |
Srijit Seal, Ola Spjuth, Layla Hosseini-Gerami, Miguel García-Ortegón, Shantanu Singh, Andreas Bender, Anne E. Carpenter. Insights into Drug Cardiotoxicity from Biological and Chemical Data: The First Public Classifiers for FDA Drug-Induced Cardiotoxicity Rank. Journal of Chemical Information and Modeling 2024; 64(4): 1172 doi: 10.1021/acs.jcim.3c01834
|
| 3 |
Hongyuan Liu, Li Hu, Xi Yang, Zian Xu, Hao Gu, Hui Chen, Xiaoxi Lin. Dabigatran etexilate is efficacious in consumptive coagulopathy and pain associated with venous malformations. Journal of Vascular Surgery: Venous and Lymphatic Disorders 2023; 11(2): 397 doi: 10.1016/j.jvsv.2022.09.015
|
| 4 |
Christoph Sucker, Thomas Dörner. Aktuelle Aspekte und Strategien zum Einsatz oraler Antikoagulantien
und Plättchenfunktionshemmer in der Praxis. Aktuelle Rheumatologie 2022; 47(06): 506 doi: 10.1055/a-1857-5295
|